Laksh Aithani

Impresa Management LLC(Impresa Management) is a Private Equity/Venture Capital firm, a subsidiary of Devonshire Investors LLC founded in 1946.The firm is headquartered in Boston.

OrbiMed Advisors Private Equity (OrbiMed Advisors Private Equity) is a private equity and venture capital subsidiary of Orbimed Advisors LLC founded in 1993 by Samuel D. Isaly. The firm is headquartered in New York and it has additional offices in San Francisco, Mumbai, Shanghai, Herzliya, Hong Kong and London.

Flagship Pioneering (Flagship Pioneering) is a venture capital firm founded in 1982 by Ed M Kania and Noubar B Afeyan. The firm is headquartered in Cambridge, Massachusetts.

Minnesota Steel Industries LLC manufactures steel. It incorporated the commercially available technology in mining, concentrating, pellet plant, DRI and electric arc steelmaking on a single site, making it one of the lowest cost steel producers in the world. The company is headquartered in St. Paul, MN.

Coley Pharmaceutical Group, Inc. manufactures drugs to treat chronic diseases. The company discovers and develops receptors therapeutic candidates for cancers, asthma, and allergic disorders. It was founded in 1997 and is headquartered in Wellesley, MA

Liberate Bio, Inc. develops novel genetic medicines. The company is based in Boston, MA. The company was founded by Michael Mitchell, Nessan Bermingham, Stephen Scully, Theresa M. Reineke. The CEO is Shawn Davis.

EveryONE Medicines, Inc. delivers individualized precision therapeutics customized to the unique pathogenic genetic mutation of patients. EveryONE Medicines is based in Boston, MA. The company's goal is to provide quality of life to patients by slowing or even halting their disease. The company was founded by Julia Vitarello and Keith Flanagan. The CEO is Nessan Bermingham.

Deep Genomics, Inc. provides machine learning, genome biology and precision medicine. It develops an integrated computational system that could learn, predict, and interpret how genetic variation, whether natural or therapeutic, alters crucial cellular processes. The firm offers SPIDEX database, which is a set of genetic variants and their predicted effects on human splicing across the entire genome. Its SPIDEX database covers all synonymous, missense, and nonsense exonic SNVs, as well as intronic SNVs that are up to 300nt from splice junctions. The company was founded by Brendan Frey and Hui Yuan Xiong in 2015 and is headquartered in Toronto, Canada.

Khosla Ventures LLC (Khosla Ventures) is a venture capital firm founded in 2004 by Vinod Khosla. The firm is headquartered in Menlo Park, California.

Part of Sino Biopharmaceutical Ltd., F-Star Delta Ltd. develops antibody products to improve the treatment of serious diseases. The company is based in Cambridge, UK and was founded in 2016.

F-Star Beta Ltd. is a biopharmaceutical company that focused in the development of oncology and immune-oncology products. The company was founded on October 14, 2014 and is headquartered in Cambridge, the United Kingdom.

F-star Alpha Ltd. develops novel bispecific antibody products. It focuses on treatment of breast and gastric cancer among a population of HER2-positive patients who do not respond or become resistant to current therapies. The company was founded in October 2013 and is headquartered in Cambridge, the United Kingdom.

F-Star Therapeutics Ltd. is a biopharmaceutical company, which engages in the development of immune-oncology drugs for antibody therapies. The company was founded in 2006 and is headquartered in Cambridge, the United Kingdom.

Korro Bio, Inc. engages in the development of a bio therapeutics. It focuses on a proprietary platform designed to selectively edit messenger RNA and recode specific codons to effect changes in protein structure and function across multiple tissues. The company was founded by Jean-Fran?ois Formela, Josh Rosenthal, Nessan Bermingham, and Andrew Fraley in 2018 and is headquartered in Cambridge, MA.

F-Star Biotechnology Ltd. is a biopharmaceutical company. It discovers, develops, and manufactures bispecific antibody products. The company is headquartered in Cambridge, the United Kingdom.

F-Star Biotechnologische Forschungs- Und Entwicklungsges MBH develops improved therapeutic antibodies and antibody fragments for cancer. It is a biopharmaceutical company dedicated to developing novel bispecific antibody products that significantly improve on the current standard of care for patients with serious diseases such as cancer. The firm's modular antibody technology allows them to rapidly discover and develop bispecific antibodies by introducing additional binding sites to the constant region of an antibody. The company was founded by Florian Ruker, Gordana Wozniak-Knopp, and Gottfried Himmler on June 12, 2006 and is headquartered in Vienna, Austria.

Milvik AB provides life, accident, and health insurance services. It offers mobile-delivered micro insurance, pre-paid life, personal accident and hospitalization insurance, and pre-paid tele-doctor services. The company was founded by Per Gustaf Arne Agartsson in 2010 and is headquartered in Stockholm, Sweden.

Goldman Sachs International (GSI) is the Great Britain-based, wholly-owned brokerage subsidiary of Goldman Sachs Group UK Ltd., ultimately held by The Goldman Sachs Group, Inc. (NYSE: GS) in the US. The firm was founded in 1988 and formerly known as Trushelfco Ltd. Headquartered in London, GSI provides prime brokerage, securities lending, futures services and financing services for a range of clients such as corporations, financial institutions, governments and high-net worth individuals.

Cityblock Health, Inc. engages in building a personalized health system that serves qualifying Medicaid or Medicare members. It offers connected services that provides communication with local service providers, convenient care which health happens at home and in the communities, and localized solutions which is customize approach to specific local needs. The company was founded by Iyah Romm, Mat Balez and Toyin Ajayi in October 2017 and is headquartered in Brooklyn, NY.

Evercore Group LLC is a SEC-registered broker/dealer headquartered in New York City. The firm was founded in 1995 and is a subsidiary of Evercore BD Investco LLC, which is owned by Evercore, Inc. (NYSE: EVR). Evercore Group delivers equity research and equity sales and agency trading execution, in addition to providing wealth and investment management services to high net worth and institutional investors.

AviadoBio Ltd. is a gene therapy company based in London, UK. AviadoBio's technology is based on pioneering research from King's College London and the UK Dementia Research Institute. The British company's mission is to develop and deliver transformative gene therapies for neurodegenerative disorders, including frontotemporal dementia (FTD) and amyotrophic lateral sclerosis (ALS). The company is developing AVB-101 for patients with FTD-GRN. AviadoBio's investors include New Enterprise Associates (NEA), Monograph Capital, Advent Life Sciences, EQT Lifesciences, Dementia Discovery Fund (DDF), F-Prime Capital, Johnson & Johnson Innovation – JJDC, Inc. (JJDC), and LifeArc. The company was founded by Youn Bok Lee, Do Young Lee, Chris E. Shaw, and Lisa Deschamps has been the CEO of the company since 2021.

Part of Sword Health SA, Sword Health, Inc. is a company that provides MSK solutions to help individuals return to work without surgery. The company is based in Draper, TX. The company's solutions include wearable sensors, digital physical therapists, and pain education resources. The company was founded in 2015 by Virgilio Bento. Virgilio Bento has been the CEO since 2015.

L.E.K. Consulting is a global strategy consulting firm that specializes in corporate strategy, transaction services, and performance improvement. Founded in 1983, L.E.K. currently employs over 900 professionals in 20 offices worldwide. Global clients include Fortune 500, FTSE 100, Eurotop 300, and many of the largest firms in Asia-Pacific. With a reputation for solving the most complex issues, L.E.K. collaborates with business leaders to accelerate the pace and precision of strategic decision-making.

Aidoc Medical Ltd. designs and develops a platform that improves the process of analyzing medical scans for radiologists. It uses a learning technology that analyzes medical images and patient data in order to detect and highlight critical abnormalities. The company was founded by Elad Walach, Michael B. Braginsky and Guy Reiner in 2016 and is headquartered in Tel Aviv, Israel.

Overjet, Inc. provides technology related services. It offers software for analyzing dental data. The company is headquartered in Wilmington, DE.

Sword Health SA manages an application providing physical therapy assistance. Its solutions include digital therapist, motion trackers, clinical portal, and others. The company was founded by Virg?lio Antonio Ferro Bento, David Manuel Dieteren Ribeiro, V?tor Pedro Tedim Ramos Cruz and Marcio Filipe Moutinho Colunas on May 6, 2013 and is headquartered in Porto, Portugal.

Cedar Cares, Inc. develops and operates an online platform for streamlined billing. Its technology provides workflow management and segmentation, analytics, custom dashboards and alerts, training and ongoing support, comprehensive billing and early out solutions, lock-box and payment reconciliation, revenue cycle management, and data science. The company was founded by Arel Lidow and Florian Otto and is headquartered in New York, NY.

General Catalyst LLC (General Catalyst) is a venture capital firm founded in 2000 by Joel Cutler, David Fialkow, Bill Fitzgerald, David Orfao and John Simon. The firm is headquartered in Cambridge, Massachusetts.

Kinnevik New Ventures AB. (KNV) is a venture capital subsidiary of Kinnevik AB founded in 1936. The firm is headquartered in Stockholm, Sweden.

Part of City Portfolio Ltd., CityBlock Holdings Ltd. acquires and develops commercial and residential properties for letting. The company is based in Lancaster, UK. The British company was founded in 2002. CityBlock Holdings was acquired by City Portfolio Ltd. from Cityblock Plc on August 31, 2007 for $4.17 million.